PD-L1 expression was not associated with progression-free or overall survival in CRC patients treated with ICIs, and there was no significant difference between responders and non-responders in PD-L1 expression in pre-treatment samples from patients with dMMR metastatic CRC [32,97]. The gene discussed is CD274; the disease is colorectal carcinoma.